peptide elongation factor 2 has been researched along with Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, AO; Furdui, CM; Holland, CE; Kasica, NP; Koscielniak, E; Lee, J; Ma, T; Ryazanov, AG; Wang, X; Wu, H; Yang, Q; Yang, W; Zhou, X; Zimmermann, HR | 1 |
1 other study(ies) available for peptide elongation factor 2 and Syndrome
| Article | Year |
|---|---|
Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Elongation Factor 2 Kinase; Mice; Peptide Elongation Factor 2; Phosphorylation; Syndrome | 2022 |